Lactobacillus paracasei L9 improves colitis by expanding butyrate-producing bacteria that inhibit the IL-6/STAT3 signaling pathway-Reference-Cited by-同舟云学术

Lactobacillus paracasei L9 improves colitis by expanding butyrate-producing bacteria that inhibit the IL-6/STAT3 signaling pathway

Published:2021 Issue:21 Volume:12 Page:10700-10713
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Deng Min¹,Wu Xi¹,Duan Xiaoyue¹,Xu Jiuzhi¹,Yang Xu¹,Sheng Xiaole¹,Lou Pengbo¹,Shao Chunlei¹,Lv Cong²,Yu Zhengquan¹^ORCID

Affiliation:

1. State Key Laboratories for Agrobiotechnology, Department of Nutrition and Health, College of Biological Sciences, China Agricultural University, Beijing, 100193, China

2. Key Laboratory of Precision Nutrition and Food Quality, Ministry of Education, Department of Nutrition and Health, China Agricultural University, Beijing, 100193, China

Abstract

We demonstrated that Lactobacillus paracasei L9 attenuates DSS-induced colitis by expanding butyrate-producing bacteria and inhibiting the IL-6/STAT3 signaling pathway.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2021/FO/D1FO02077C

Reference67 articles.

1. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies